Valor pronóstico de los niveles plasmáticos de sTREM-1 en pacientes con sepsis: un estudio de cohortes / Prognostic value of the sTREM-1 plasma values in patients with sepsis: A cohort study

Objetivo: Evaluar la asociación entre los niveles plasmáticos de soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) y la mortalidad de los pacientes con sepsis. Diseño: Estudio de cohortes prospectivo. Ámbito: Dos unidades de cuidados intensivos generales. Pacientes: Pacientes con sepsis en los que se determinaron los niveles plasmáticos de sTREM-1 durante los 3 primeros días de su presentación. Variables de interés principales: Mortalidad a los 28 días. Resultados: Se analizaron 121 pacientes (el 23% sepsis grave, el 44% shock séptico y el 33% sepsis no grave). La mortalidad a los 28 días fue del 24,8%. Los niveles de sTREM-1 iniciales fueron ligeramente más elevados en los fallecidos que en los supervivientes (mediana de 366,9 frente a 266,5pg/ml; p=0,2668). Una elevación de los niveles de sTREM-1 a lo largo de los 3 primeros días (delta-TREM) superior a 90pg/ml se asoció con un exceso de mortalidad (hazard ratio: 2,68; p=0,0047), con una sensibilidad del 47% y una especificidad del 78%. Este exceso de mortalidad de los pacientes desapareció al ajustar para gravedad mediante análisis de Cox (hazard ratio ajustado de 1,07; p=0,8665). Conclusiones: En pacientes críticos con sepsis, el aumento de los niveles de sTREM-1 a lo largo de los 3 primeros días de evolución se asocia con un exceso de mortalidad, que se explica por la mayor gravedad inicial de estos pacientes. La capacidad discriminativa de este hallazgo es insuficiente para ser útil en la clínica (AU)

Objective: To evaluate the association between plasma levels of soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and mortality of patients with sepsis. Design: Prospective cohort study. Setting: Two general Intensive Care Units. Patients: Patients with sepsis in whom sTREM-1 plasma levels were determined daily in the first 3 days of their presentation. Variables of interest: Mortality at 28 days. Results: We analyzed 121 patients (23% severe sepsis, 44% septic shock, 33% non-severe sepsis). Mortality at 28 days was 24.8%. The initial sTREM-1 levels were slightly higher in nonsurvivors than in survivors (median 366.9 versus 266.5pg/ml, p=0.2668). An increase in sTREM-1 levels higher than 90pg/ml within the first 3 days (delta-TREM) was associated with an excess of mortality (hazard ratio [HR] 2.68, p=0.0047), with a sensitivity of 47% and a specificity of 78%. This excess of mortality disappeared after adjusting for severity by Cox analysis (adjusted HR 1.07, p=0.8665). Conclusions: The increase in the levels of sTREM-1 during the first 3 days of evolution is associated with an excess of mortality in critically ill patients with sepsis. This is explained by the greater initial severity of these patients. The discriminative capacity of this finding is insufficient to be clinically useful (AU)

[Prognostic value of the sTREM-1 plasma values in patients with sepsis: a cohort study]. / Valor pronóstico de los niveles plasmáticos de sTREM-1 en pacientes con sepsis: un estudio de cohortes.

OBJECTIVE: To evaluate the association between plasma levels of soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and mortality of patients with sepsis. DESIGN: Prospective cohort study. SETTING: Two general Intensive Care Units. PATIENTS: Patients with sepsis in whom sTREM-1 plasma levels were determined daily in the first 3 days of their presentation. VARIABLES OF INTEREST: Mortality at 28 days. RESULTS: We analyzed 121 patients (23% severe sepsis, 44% septic shock, 33% non-severe sepsis). Mortality at 28 days was 24.8%. The initial sTREM-1 levels were slightly higher in nonsurvivors than in survivors (median 366.9 versus 266.5 pg/ml, p=0.2668). An increase in sTREM-1 levels higher than 90 pg/ml within the first 3 days (delta-TREM) was associated with an excess of mortality (hazard ratio [HR] 2.68, p=0.0047), with a sensitivity of 47% and a specificity of 78%. This excess of mortality disappeared after adjusting for severity by Cox analysis (adjusted HR 1.07, p=0.8665). CONCLUSIONS: The increase in the levels of sTREM-1 during the first 3 days of evolution is associated with an excess of mortality in critically ill patients with sepsis. This is explained by the greater initial severity of these patients. The discriminative capacity of this finding is insufficient to be clinically useful.

Útero gigante / Giant uterus

Presentamos el caso clínico de una mujer de43 años con aumento del perímetro abdominalde un año de evolución. El volumen del abdomenfue notorio en los últimos meses adquiriendouna consistencia dura y acompañándosede pérdida de 10kgr. de peso. Ante tal tumoraciónabdominal gigante y con sospecha de probableorigen mesentérico, sin poder definir origenni naturaleza, se decidió extirpación quirúrgicadel tumor, encontrando una gran tumoraciónabdominal dependiente de útero, tratándosede un útero gigante de 5.250 kilogramoscon un único mioma

We report on the case of a 43-year-old female;;patient who complained of progressive increase;;in abdominal perimeter during the last year,;;along with weight loss of approximately 10 kg.;;On clinical examination there was abdominal;;tenderness. CT scan revealed a great abdominal;;mass, apparently spawning from the mesenterium.;;At surgery, the tumor was found to stem;;from the uterus, and weightened 5.25 kgr. The;;histopathological report informed of myoma